We are live on !
Find out more
Rangeley Capital Portfolio holdings
AUM
$109M
Turnover
49.06%
1-Year Est. Return
97.13%
This Fund
S&P 500
This Quarter Est. Return
+34.11%
1 Year Est. Return
+97.13%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$109M
AUM Growth
+$6.53M
(+6.3%)
Cap. Flow
-$6.26M
Cap. Flow % of AUM
Cap. Flow %
-5.72%
Top 10 Holdings %
Top 10 Hldgs %
32.08%
Holding
212
New
75
Increased
28
Reduced
43
Closed
29
Avg Time Held
Equity + Options
0.4
years
Top 10 Avg Time Held
Equity + Options
0.3
years
Top 20 Avg Time Held
Equity + Options
0.4
years
Avg Time Held Equity only
0.4
years
Top 10 Avg Time Held Equity only
0.3
years
Top 20 Avg Time Held Equity only
0.4
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Nomad Foods
NOMD
|
+$1.34M |
| 2 |
Mountain Lake Acquisition Corp II
MLAA
|
+$1.27M |
| 3 |
Distribution Solutions Group
DSGR
|
+$1.26M |
| 4 |
enGene Therapeutics
ENGN
|
+$1.24M |
| 5 |
Abivax
ABVX
|
+$1.02M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Revolution Medicines
RVMD
|
+$8.47M |
| 2 |
Leggett & Platt
LEG
|
+$2.1M |
| 3 |
Icon
ICLR
|
+$1.96M |
| 4 |
Kezar Life Sciences
KZR
|
+$1.8M |
| 5 |
Mister Car Wash
MCW
|
+$1.54M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 27.11% |
| 2 | Consumer Discretionary | 14.33% |
| 3 | Financials | 12.51% |
| 4 | Miscellaneous | 10.11% |
| 5 | Real Estate | 9.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
26
Mountain Lake Acquisition Corp II
MLAA
| $1.27M | 1.16% |
+127,791
| New | +$1.27M |
2026 Q2
0 quarters
|
|
27
Entravision Communication
EVC
$565M
| $1.19M | 1.08% |
91,000
-9,000
| -9% | -$63.8K |
2025 Q4
2 quarters
|
|
28
Rapid7
RPD
$1.21B
| $1.16M | 1.06% |
+143,000
| New | +$948K |
2026 Q2
0 quarters
|
|
29
Bicycle Therapeutics
BCYC
$255M
| $1.07M | 0.98% |
253,500
+21,240
| +9% | +$97.4K |
2025 Q2
4 quarters
|
|
30
Net Lease Office Properties
NLOP
$141M
| $1.06M | 0.97% |
95,000
-19,870
| -17% | -$239K |
2024 Q4
6 quarters
|
|
31
Kura Oncology
KURA
$856M
| $1.03M | 0.94% |
94,000
-7,220
| -7% | -$68.1K |
2025 Q2
4 quarters
|
|
32
Willis Lease Finance
WLFC
$818M
| $915K | 0.84% |
+12,000
| New | +$784K |
2026 Q2
0 quarters
|
|
33
Wen Acquisition Corp
WENN
$392M
| $897K | 0.82% |
88,113
+3,113
| +4% | +$31.9K |
2025 Q3
3 quarters
|
|
34
Huckleberry.ai, Inc. Class B Common Stock
HUCK
$146M
| $864K | 0.79% |
276,000
+250,000
| +962% | +$836K |
2026 Q1
1 quarter
|
|
35
Meta Platforms (Facebook)
META
$1.61T
| $845K | 0.77% |
+1,500
| New | +$917K |
2026 Q2
0 quarters
|
|
36
Rayonier Advanced Materials
RYAM
$438M
| $824K | 0.75% |
+104,808
| New | +$951K |
2026 Q2
0 quarters
|
|
37
Immersion
IMMR
$236M
| $745K | 0.68% |
110,000
+35,000
| +47% | +$221K |
2026 Q1
1 quarter
|
|
38
Forward Air
FWRD
$509M
| $743K | 0.68% |
55,000
-30,000
| -35% | -$447K |
2025 Q3
3 quarters
|
|
39
InMode
INMD
$790M
| $731K | 0.67% |
+50,000
| New | +$698K |
2026 Q2
0 quarters
|
|
40
DoubleDown Interactive
DDI
$675M
| $700K | 0.64% |
+61,000
| New | +$656K |
2026 Q2
0 quarters
|
|
41
Calumet Specialty Products
CLMT
$4.59B
| $684K | 0.63% |
19,000
-34,000
| -64% | -$1.14M |
2024 Q4
6 quarters
|
|
42
Xponential Fitness
XPOF
$174M
| $675K | 0.62% |
+97,485
| New | +$617K |
2026 Q2
0 quarters
|
|
43
Charter Communications
CHTR
$11.7B
| $640K | 0.58% |
+4,500
| New | +$751K |
2026 Q2
0 quarters
|
|
|
BCAR
44
DELISTED
D. Boral ARC Acquisition I Corp
BCAR
| $638K | 0.58% |
+61,150
| New | +$641K |
2026 Q2
0 quarters
|
|
45
Axiom Intelligence Acquisition Corp 1
AXIN
$283M
| $633K | 0.58% |
+61,193
| New | +$628K |
2026 Q2
0 quarters
|
|
46
Roman DBDR Acquisition Corp II
DRDB
$330M
| $632K | 0.58% |
60,000
| – | – |
2025 Q3
3 quarters
|
|
47
Grocery Outlet
GO
$1.29B
| $629K | 0.57% |
63,000
+23,000
| +58% | +$189K |
2026 Q1
1 quarter
|
|
48
Phibro Animal Health
PAHC
$1.58B
| $628K | 0.57% |
+20,000
| New | +$844K |
2026 Q2
0 quarters
|
|
49
Cohen Circle Acquisition Corp II
CCII
$357M
| $616K | 0.56% |
60,200
+50,200
| +502% | +$516K |
2025 Q4
2 quarters
|
|
50
Yext
YEXT
$734M
| $609K | 0.56% |
130,328
+31,000
| +31% | +$120K |
2025 Q3
3 quarters
|
|
Similar funds
S2L
Rangeley Capital's Q2 2026 Portfolio in Review
As of Q2 2026, Rangeley Capital held 212 positions worth $109M, up 6.3% from $103M the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Rangeley Capital withdrew a net $6.26M in Q2 2026, closing 29 positions and reducing 43 holdings. Its most notable exit was Leggett & Platt, an estimated $2.1M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 27% of assets, down from 29% a quarter earlier, followed by Consumer Discretionary and Financials.
Against the trend, Rangeley Capital opened a new position in Nomad Foods worth $1.48M.
- Rangeley Capital's largest Q2 2026 buy was Nomad Foods: 135,000 shares worth $1.48M.
- Rangeley Capital added most to Distribution Solutions Group in Q2 2026, an estimated $1.26M increase.
- Rangeley Capital's biggest Q2 2026 reduction was Revolution Medicines, cutting an estimated $8.47M.
- Rangeley Capital fully exited Leggett & Platt in Q2 2026, selling an estimated $2.1M.
- Rangeley Capital's ten largest holdings make up 32% of its $109M portfolio in Q2 2026.
- Rangeley Capital opened 75 new positions and closed 29 in Q2 2026.
- Rangeley Capital's portfolio value rose 6.3% quarter-over-quarter to $109M.
Based on Rangeley Capital's 13F filing for Q2 2026, filed 14 Aug 2026.